NYSE$SEM
Select Medical Holdings Corporation · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Select Medical reported revenue growth in Q4 2024 but faced a loss from continuing operations due to one-time charges.
Select Medical Holdings Corporation reported a 7.8% increase in revenue for Q4 2024, reaching $1.31 billion. However, the company posted a net loss from continuing operations of $10.5 million due to a one-time stock compensation acceleration of $45.9 million and a $17.9 million loss on early retirement of debt. Adjusted EPS increased by 50% to $0.18. Adjusted EBITDA rose 3.8% to $116.0 million.
- Q4 revenue grew 7.8% YoY to $1.31 billion.
- Loss from continuing operations was $10.5 million due to one-time expenses.
- Adjusted EPS increased 50% YoY to $0.18.
- Adjusted EBITDA rose 3.8% to $116.0 million.
Headline financials
Revenue & EPS history
Select Medical · Revenue · Quarterly
$1.31B
Revenue by segment
Select Medical · $1.1B total across 3 segments · Q3 2023
- Critical Illness Recovery$564M+7.4%51.1%
- Outpatient Rehabilitation$292M+2.4%26.5%
- Rehabilitation Hospital$247M+7.7%22.4%
Forward guidance
For 2025, Select Medical expects revenue between $5.4 billion and $5.6 billion, Adjusted EBITDA between $520 million and $540 million, and diluted EPS between $1.09 and $1.19.
Tailwinds
- Revenue expected to grow to $5.4B - $5.6B in 2025.
- Adjusted EBITDA projected between $520M - $540M.
- EPS expected to rise between $1.09 - $1.19.
- Improved cost control measures expected to enhance margins.
- Expansion in rehabilitation and outpatient services planned.
Headwinds
- Continued impact of labor cost inflation on margins.
- Higher interest expenses due to recent debt refinancing.
- Potential reimbursement pressures from government programs.
- Challenges in retaining and attracting qualified healthcare professionals.
- Macroeconomic uncertainties affecting patient volumes.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
-0.3%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+0.5%
Avg return
30 days after
49%
32 / 65 earnings
Positive
+18.8%
Q3 2018
Best reaction
-22.2%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +0.1% | +0.7% | |
| Q4 2025 | -6.5% | -7.3% | +1.1% | |
| Q3 2025 | -5.8% | -5.1% | +9.1% | |
| Q1 2025 | -22.2% | -17.7% | -16.2% | |
| Q4 2024 | -7.2% | -2.9% | -13.1% | |
| Q3 2024 | +9.4% | +13.3% | +19.3% | |
| Q2 2024 | -14.0% | -17.2% | -9.3% | |
| Q1 2024 | +12.3% | +17.0% | +23.5% | |
| Q4 2023 | +6.7% | +4.6% | +7.7% | |
| Q3 2023 | -1.2% | -2.7% | +3.9% | |
| Q2 2023 | -1.3% | -2.5% | -4.3% | |
| Q1 2023 | +4.8% | -0.8% | -2.8% | |
| Q4 2022 | -7.8% | -9.1% | -17.6% | |
| Q3 2022 | -6.5% | -10.9% | +0.9% | |
| Q2 2022 | -4.1% | -11.1% | -14.7% | |
| Q1 2022 | +0.9% | -4.2% | +10.6% | |
| Q4 2021 | +1.1% | +2.2% | +3.5% | |
| Q3 2021 | +2.4% | -0.9% | -18.4% | |
| Q2 2021 | -3.3% | -6.9% | -7.7% | |
| Q1 2021 | -2.5% | -3.1% | +4.9% | |
| Q4 2020 | +10.5% | +16.9% | +20.5% | |
| Q3 2020 | -1.7% | +8.5% | +15.4% | |
| Q2 2020 | +13.1% | +14.7% | +21.2% | |
| Q1 2020 | -15.3% | -12.9% | -6.3% | |
| Q4 2019 | +8.9% | -0.1% | -55.6% | |
| Q3 2019 | +5.7% | +10.6% | +22.9% | |
| Q2 2019 | -5.8% | -5.8% | -3.1% | |
| Q1 2019 | +1.7% | +3.0% | -1.3% | |
| Q4 2018 | +0.1% | -4.8% | -10.1% | |
| Q3 2018 | +18.8% | +21.2% | +16.9% | |
| Q2 2018 | -5.0% | -7.5% | -6.6% | |
| Q1 2018 | -4.4% | -3.5% | -2.9% | |
| Q4 2017 | +11.2% | +11.4% | +7.8% | |
| Q3 2017 | -7.8% | -9.4% | -6.5% | |
| Q2 2017 | +8.6% | +12.7% | +18.7% | |
| Q1 2017 | +5.9% | +1.1% | +3.7% | |
| Q4 2016 | +9.6% | +11.6% | -3.1% | |
| Q3 2016 | -8.2% | -6.1% | -1.2% | |
| Q2 2016 | +10.6% | +6.3% | +9.3% | |
| Q1 2016 | -4.5% | — | — | |
| Q4 2015 | +10.9% | — | — | |
| Q3 2015 | +5.0% | — | — | |
| Q2 2015 | +0.1% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | -5.2% | — | — | |
| Q3 2014 | +11.3% | — | — | |
| Q2 2014 | -12.4% | — | — | |
| Q1 2014 | +0.5% | — | — | |
| Q4 2013 | +1.7% | — | — | |
| Q3 2013 | +1.1% | — | — | |
| Q2 2013 | +1.3% | — | — | |
| Q1 2013 | -2.5% | — | — | |
| Q4 2012 | +4.0% | — | — | |
| Q3 2012 | +10.0% | — | — | |
| Q2 2012 | +9.1% | — | — | |
| Q1 2011 | -3.2% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q4 2009 | -0.4% | — | — | |
| Q4 2011 | -0.4% | — | — | |
| Q3 2010 | -2.4% | — | — | |
| Q3 2011 | -2.4% | — | — | |
| Q4 2010 | -15.8% | — | — | |
| Q2 2010 | -15.8% | — | — | |
| Q2 2011 | -15.8% | — | — | |
| Q1 2010 | -7.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro